Emergence of Digital Technologies in Pharmaceutical Industry
The 8th Annual Digi-Tech Pharma & AI conference, a premier Pharmaceutical Technology Conference, brings with it even more interactive sessions, expert speakers, senior professionals and decision makers from leading pharma, bio-tech and healthcare industry. Meet the decision makers, benchmark and learn from real-life use cases to drive organizational change and to understand the new cutting-edge technologies and practical solutions. In this 8th edition as we explore the novel technologies and developments reforming pharmaceutical industry, we also dive deep into the implementation and advances in machine learning, deep learning, artificial intelligence, informatics and data science which has redefined the development of new drugs, tackle diseases, improving healthcare and much more.
The enhancements in data management and data integration are providing improvements to both the speed and quality of drug discovery and many clinical trial processes. To be in the forefront, a necessity for partnership and collaboration with healthcare provider is a must for the pharmaceutical companies, and these partnerships will also lead to massive advances in R&D using artificial intelligence in genomics and precision medicine to develop a deep understanding of the root causes of diseases.
The combination of AI, big data and IoT technologies are creating new innovations, also other eminent technologies like cloud computing, augmented reality, virtual reality and blockchain are being used extensively in the Pharmaceutical industry’s digital transformation.
Key Highlights
- Reimagining Pharma by Integrating Science and Technology:
- Digital Technology trends in Pharma and Bio-Tech industry
- Adopting AI and Machine Learning to unlock the full potential of Pharma
- How pharma can integrate into digital health environment
- Collaborative Innovation: Finding the right partners to leverage new technologies in Pharma
- Patient Centred Drug Discovery
- Digital Discovery and Clinical Trials:
- Applying AI to the design of lead compounds for new drugs
- Algorithms and Models for drug discovery
- AI and ML for Target Identification & Validation in Drug Discovery
- Advancing Drug Discovery through quantum computing
- Genomics & Drug Discovery
- Virtual and Hybrid Clinical Trials
- R&D Use Cases
- Decoding the Value of Data Science, Big Data & Informatics:
- Implementation and relevance of FAIR data principles in Pharma R&D
- Harnessing Data Science for Drug Combination Discovery
- AI and Big Data: A powerful combination for future growth
- The use of AI to make sense of clinical data
- Use of big data for precision medicine
- Multi-omics & clinical data to unlock the power of complex datasets
- Integration and Visualization of translational Medicine Data
- Data & Healthcare Analytics
- Real-World Data & Real-World Evidence:
- The Growing Importance of Real-World Data
- RWD for clinical research and drug development
- RWE and RWD to support regulatory decision making
- Real-World Data Science to advance Patient Care
- Managing real world data governance
- Digital Health & Future Innovations:
- Healthcare & Medical Technology
- Adoption of IoT in Pharma
- Potential of Cloud Computing in Pharma
- Impact of Digital Health in Pharma
- Digital Health strategy and Patient centric Clinical Trials
- The convergence of Digital Therapeutics and Pharma in Digital Health
- How pharma-health collaboration works on innovating drug discovery & patient experience
- Blockchain and AI-based Platform
Agenda
Day 1
08:15: Registration & Refreshments
Kick off your conference experience by checking in at our registration desk. Collect your event materials and enjoy a selection of refreshments. It's the perfect time to mingle with fellow attendees and set the tone for an engaging and informative event
08:50: Welcome Address & Chairperson’s opening remarks
Begin your conference journey with a warm welcome from our esteemed Chairperson
Bruce Hellman
Co-Founder & Chief Patient Officer
uMotif
09:00: Digital Transformation: Developing and deploying a digital authoring platform across the value chain
Use of AI in clinical document development
Taking a holistic approach, expanding beyond clinical documentation
Deployment strategy, making digital tools operational
Value generation today and in the future, speeding up submission file creation
Louise Lind Skov
Head of Content Digitalisation
Novo Nordisk
Waheed Jowiya
Digitalisation Strategy Lead
Novo Nordisk
09:30: Can drug repurposing be saved with artificial intelligence?
Paul Agapow
Director
GSK
10:00: Beyond the molecule: when software understands the patient
Gary Crawford
Chief Innovation Officer
Waracle
10:40: Business Card Exchange with Morning Coffee/Tea & Discussion
Network over morning coffee or tea, exchanging business cards or using our app's QR code scanner for easy contact sharing. A prime moment for engaging discussions and new connections
11:00: Collaborative Innovation: Finding the right partners to leverage new technologies in Pharma
How early-stage partnering and collaboration will inhibit pharma innovation
How Biotech revolution has changed the face of drug development?
Working with incubators, accelerators and innovation forums can also help
Having a good governance structure in place
Konrad Dobschuetz
Global Health
Tech Leader
Former National Director NHS Innovation Accelerator
11:30: Implementation and Relevance of FAIR Data Principles in Big Pharma
Improving the efficiency and effectiveness by implementing the FAIR guiding principles for scientific data
Tools enabling FAIR data
Fair as a machine learning enabler
Benefits of FAIR in pharma
Jimmy Toulas
Real World and Commercial Data Director, EMEA & China
Pfizer
12:00: Network models in drug discovery and development
Julio Molineros
Associate Director
Johnson & Johnson Innovative Medicine
12:30: Luncheon & Networking - Explore, Engage with Your Peers, and Connect at Our Exhibitor Booths
Enjoy a luncheon while networking with peers and exploring exhibitor booths. This is an ideal time to engage with industry leaders, delve into innovative solutions, and forge valuable connections in a collaborative atmosphere.
13:25: The evolving patent landscape at the intersection of biotechnology and AI
Luke Tregilgas
Patent Attorney
Haley Guiliano
13:50: Case Study - How Novo Nordisk leverage in silico tools like AI/ML and genetics to reach strategic priorities
Jakob E. Larsen
Target Discovery Engine Project Director
Novo Nordisk
14:20: Essential innovations to unlock the potential of precision medicine
Guillaume Desachy
Head of Biometrics
Pierre Fabre
14:45: The impact of AI in Biologics discovery and optimisation for Pharma
Andrew Buchanan
Principal Scientist
AstraZeneca
15:15: Recharge with Tea or Coffee While Networking
Refresh with a tea or coffee break, using this time to continue networking. It's a perfect opportunity to discuss ideas, share experiences, and connect with fellow attendees in a relaxed setting.
15:35: The Impact of Multi-omic Analysis/Integration in Diagnosing Disease and Driving Drug Development
James Duboff
Strategic Partnerships Director
Genomics England
16:05: Connected data and single patient jackets for precision health
Andy Cachaldora
General Manager Digital Service Northern Europe
GE Healthcare
16:35: Corporate start-up partnerships in digital health
Dan Ma
Head of Innovation & New Commercial Partnerships | Head Sandoz Innovation Lab Germany
Sandoz
Benjamin Friedrich
Chief Medical Officer & Co-Founder
Temedica
17:05: AI in Oncology: Personalizing Cancer Treatment and Care
Rafik Fellague-Chebra
Executive Global Group medical Director
Novartis Oncology
17:30: Executives Discussion and Debate: Empowering drug discovery and development: the AI and Machine Learning revolution?
How pharmaceutical companies are adopting AI to discover new drugs and improve existing ones, and the impact this is having on their R&D strategies
How AI is not just a tool for research but is reshaping business models, leading to collaborations with tech companies, the rise of AI-driven biotech firms, and changes in investment strategies
Strategies to maximize AI & ML's impact in drug discovery and development
Mitigating risks and uncertainties in drug development through AI. Explore how AI is being used to navigate the complexities of both early-stage discovery and late-stage clinical trials
Bruce Hellman
Co-Founder & Chief Patient Officer
uMotif
Jakob E. Larsen
Target Discovery Engine Project Director
Novo Nordisk
Julio Molineros
Associate Director
Johnson & Johnson Innovative Medicine
Marianna Esposito
Business Development Director
Intelligencia AI
Victor Barzey
Product Lead, Digital Healthcare
Otsuka Pharmaceutical Companies Europe
18:00: Graph-in, graph-out: how graph Retrieval Augmented Generation (g-RAG) improves business value delivery out of Large Language Models
Cedric Berger
Head of Knowledge Extraction and Integration
Roche
18:30: Chair Person's Closing remarks
End the conference with the Chairperson's closing remarks, summarizing key insights and leaving attendees with final thoughts to inspire ongoing engagement and action.
18:40: Networking Drinks Session - Unwind with Evening Drinks and Engaging Conversations
Wrap up the day with evening drinks and lively conversations. A relaxed setting to network, share insights from the day, and enjoy the company of fellow attendees.
Day 2
08:15: Registration & Refreshments
Start the second day of the conference by checking in and grabbing a morning refreshment. It’s a great opportunity to re-engage with peers, discuss the previous day’s insights, and prepare for another day of learning and networking.
08:50: Welcome Address & Chairperson’s opening remarks
Start the second day with insightful remarks from our Chairperson
Bruce Hellman
Co-Founder & Chief Patient Officer
uMotif
Bridging Pharma and Technology for Future Breakthroughs
09:00: How Real World Data is transforming drug development
Irena Brookes-Smith
Head of Healthcare Analytics
AstraZeneca
09:30: Boehringer's AI-Driven Knowledge Management Revolution
iQNow: a ground-breaking Knowledge Management Platform for over 25,000 users at Boehringer Ingelheim.
Unleashing the power of AI: iQNow offers unique features like expert identification, semantic search, and the combination and creation of knowledge.
Overcoming user challenges: streamlining information retrieval and simplifying knowledge digestion.
Liliana Montano Herrera
Senior Scientist Knowledge Management & AI
Boehringer Ingelheim
10:00: AI Partnerships with Pharma - What Pharma partners look for and key deal considerations
Daniyal Hussain
Executive Director, Technology Business Development
GSK
10:30: Business Card Exchange with Morning Coffee/Tea & Discussion
Network over morning coffee or tea, exchanging business cards or using our app's QR code scanner for easy contact sharing. A prime moment for engaging discussions and new connections.
10:50: Can't Chat
GPT Do That? Practical Applications for Generative AI in Drug Development
The popularity of tools like Chat GPT has brought AI to the forefront of tech investments, but nearly 73% of life science companies still struggle to adopt appropriate AI technologies. This outcome ultimately stems from model accuracy data access and privacy concerns that lead to failed implementation. In this session, attendees will receive an interactive presentation how innovative approaches can overcome these challenges to lead to successful AI use across drug R&D.
Nick Brown
Director, Global Portfolio Leader
Certara
11:15: The IT Architecture for AI in Pharma R&D
Hassan Abba
Head of Architecture R&D
AstraZeneca
11:45: Unlocking ROI for Generative AI use cases-Designing the right framework
Ritesh Dogra
Associate Vice President, Medical Tech Commercialization
Indegene
12:05: Integrating Multimodal Data for Computational Phenotyping
A. Sinan Yavuz
Manager, ZS Discovery
ZS
12:30: Luncheon & Networking - Explore, Engage with Your Peers, and Connect at Our Exhibitor Booths
Enjoy a luncheon while networking with peers and exploring exhibitor booths. This is an ideal time to engage with industry leaders, delve into innovative solutions, and forge valuable connections in a collaborative atmosphere.
13:20: Building a High Throughput AI and Physics-based Drug Screening Platform: And its Application in Drug Designing
Sudip Roy
Chief Executive Officer
Prescience Insilico
13:40: Implementation of Gen AI Adoption Strategies for Pharma Corporate Functions
Marcos Camara
Digital Solutions Senior Manager
Astellas Pharma Europe
14:10: Leveraging AI to Enhance Clinical Trials
Claudia Wiedemann
Associate Director Data Science Digital Health
Evinova
14:40: Pivotal role of Data Integration in Enabling pharma to fit its drug development strategy while accelerating innovation
Integrating data from distinct sources and leverage predictive analytics to drive informed, real-time decisions
Deep Learning based multi-omics data integration
Role of data integration and analytics and how it helps in faster decision making and clinical trials.
Implementing end-to-end data integration
Hassan Khalid
Senior Engineer, Machine Learning and Data Science
AstraZeneca
15:10: Recharge with Tea or Coffee While Networking
Refresh with a tea or coffee break, using this time to continue networking. It's a perfect opportunity to discuss ideas, share experiences, and connect with fellow attendees in a relaxed setting.
15:30: Are we focusing on the real challenges with DTx?
Spencer Jones
Founder and CEO
Stealth Heathcare Start-up
16:00: Preparation of the ecosystem at corporation level to enhance innovation.
Anastassia Anastassopoulou
European Advanced Analytics Strategy Director
Daiichi Sankyo Europe GmbH
16:30: Beyond Buzzwords: Deciphering AI vs Traditional IT Realities
Practical insights from 100+ projects
Inspiring success stories where AI and advanced analytics delivered business impact in pharma
Navigating common challenges in AI projects
Marina Borozna
Head of Data Strategy
Ipsen
17:00: Panel Discussion: Advancing Drug Discovery and Patient Care: The Synergy of Emerging Technologies in Pharma-Health Collaboration
Why is it important for pharma and healthcare to work together?
The changing patient behaviour in the digital era
Why is it essential to be prompt in identifying and addressing the patient’s needs?
How will digitization help bring patients on board?Progress made by companies so far
Strategies to be adopted to increase patient-company data flow
Mike Miller
Client Principal
Waracle
Daniyal Hussain
Executive Director, Technology Business Development
GSK
Hassan Khalid
Senior Engineer, Machine Learning and Data Science
Astra
Zeneca
Claudia Wiedemann
Associate Director Data Science Digital Health
Evinova
17:30: Closing remarks
End the conference with the Chairperson's closing remarks, summarizing key insights and leaving attendees with final thoughts to inspire ongoing engagement and action.
Speakers
Bruce Hellman
Co-Founder & Chief Patient Officer
uMotif
Konrad Dobschuetz
Global HealthTech Leader
former National Director NHS Innovation Accelerator
Jakob E. Larsen
Target Discovery Engine Project Director
Novo Nordisk
Mike Miller
Client Principal
Waracle
Paul Agapow
Director
GSK
Cedric Berger
Head of Knowledge Extraction and Integration
Roche
Julio Molineros
Associate Director
Johnson & Johnson Innovative Medicine
James Duboff
Strategic Partnerships Director
Genomics England
Louise Lind Skov
Head of Content Digitalisation
Novo Nordisk
Andy Cachaldora
General Manager Digital Service Northern Europe
GE Healthcare
Spencer Jones
Founder and CEO
Stealth Heathcare Start-up
Irena Brookes-Smith
Head of Healthcare Analytics
AstraZeneca
Daniyal Hussain
Executive Director, Technology Business Development
GSK
Waheed Jowiya
Digitalisation Strategy Lead
Novo Nordisk
Marcos Camara
Digital Solutions Senior Manager
Astellas Pharma Europe
Jimmy Toulas
Real World and Commercial Data Director, EMEA & China
Pfizer
Hassan Abba
Head of Architecture R&D
AstraZeneca
Hassan Khalid
Senior Engineer, Machine Learning and Data Science
AstraZeneca
Liliana Montano Herrera
Senior Scientist Knowledge Management & AI
Boehringer Ingelheim
Anastassia Anastassopoulou
European Advanced Analytics Strategy Director
Daiichi Sankyo Europe GmbH
Guillaume Desachy
Head of Biometrics
Pierre Fabre
Sudip Roy
Chief Executive Officer
Prescience Insilico
Dan Ma
Head of Innovation & New Commercial Partnerships | Head Sandoz Innovation Lab Germany
Sandoz
Andrew Buchanan
Principal Scientist
AstraZeneca
Marianna Esposito
Business Development Director
Intelligencia AI
Marina Borozna
Head of Data Strategy
Ipsen
Rafik Fellague-Chebra
Executive Global Group medical Director
Novartis Oncology
Claudia Wiedemann
Associate Director Data Science Digital Health
Evinova
Gary Crawford
Chief Innovation Officer
Waracle
Luke Tregilgas
Patent Attorney
Haley Guiliano
A. Sinan Yavuz
Manager, ZS Discovery
ZS
Ritesh Dogra
Associate Vice President, Medical Tech Commercialization
Indegene
Nick Brown
Director, Global Portfolio Leader
Certara
Victor Barzey
Product Lead, Digital Healthcare
Otsuka Pharmaceutical Companies Europe
Benjamin Friedrich
Chief Medical Officer & Co-Founder
Temedica
Who Should Attend
This event is designed for senior level attendees from various companies including pharmaceutical, biotechnological, biopharmaceutical, CRO’s, Diagnostics, solution provider and government institutions. Attendees includes Chief Data Officer, VPs, GMs, Directors, Heads and Managers of:
- Drug Discovery
- Drug Delivery Innovation
- R&D IT
- Big Data Solutions
- AI/ Machine Learning
- Cognitive Computing
- Digital innovative strategic planning
- Regulatory and pharmacovigilance
- IT Strategy
- Real-World Data
- Real-World Evidence
- Data Management & Analytics
- Data Science
- Clinical trials and data management
- Translational informatics
- Data storage and analysis
- Enterprise Architecture
- Information Systems
- Contract outsourcing service providers
- Digital Health
- Genomics
- Healthcare IT
- Multi-channel Management
Location
ADDRESS
London
United Kingdom
Venue to be announced shortly.
